0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Budget Docs
Contact
Alliance Archives
Join Us
Advocacy at a Glance Guest User 5/18/18 Advocacy at a Glance Guest User 5/18/18

House Appropriations Committee Passes Ag/FDA Bill With $308 Million Increase and more

Read More
Advocacy at a Glance Guest User 5/11/18 Advocacy at a Glance Guest User 5/11/18

House Appropriations Bill Provides FDA with a $300+ Million Increase and more

Read More
Advocacy at a Glance Guest User 5/4/18 Advocacy at a Glance Guest User 5/4/18

Congress Returns May 7; Starts 11-Week Sprint to August Recess and more

Read More
Advocacy at a Glance Guest User 4/27/18 Advocacy at a Glance Guest User 4/27/18

Alliance’s Advocacy Day a Success!

Read More
Advocacy at a Glance Guest User 4/21/18 Advocacy at a Glance Guest User 4/21/18

Alliance’s Hill Day on April 25. Please Join Us

Read More
Advocacy at a Glance Guest User 4/13/18 Advocacy at a Glance Guest User 4/13/18

Notes from the Alliance’s Meeting with CBER Director Peter Marks and more

Read More
Advocacy at a Glance Guest User 4/6/18 Advocacy at a Glance Guest User 4/6/18

Support FDA By Participating In the Alliance’s Hill Day on April 25

Read More
Advocacy at a Glance Guest User 3/23/18 Advocacy at a Glance Guest User 3/23/18

Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more

Read More
Advocacy at a Glance Guest User 3/16/18 Advocacy at a Glance Guest User 3/16/18

Unclear Whether Congress Can Avoid Brinksmanship and more

Read More
Advocacy at a Glance Guest User 3/11/18 Advocacy at a Glance Guest User 3/11/18

FDA’s Breakthrough Device Program Featured and more

Read More
Advocacy at a Glance Guest User 3/3/18 Advocacy at a Glance Guest User 3/3/18

Making the Case: The Alliance's "Ask" for FY 19

Read More
Advocacy at a Glance Guest User 3/3/18 Advocacy at a Glance Guest User 3/3/18

Alliance Announces Its FY 19 Request; Tells Congress that FDA Needs More Support and more

Read More
Advocacy at a Glance Guest User 2/23/18 Advocacy at a Glance Guest User 2/23/18

Congress Was in Recess and the Alliance Was Busy and more

Read More
Advocacy at a Glance Guest User 2/16/18 Advocacy at a Glance Guest User 2/16/18

Major Boost for Medical Products, No Increase for Food Safety and more

Read More
Advocacy at a Glance Guest User 2/9/18 Advocacy at a Glance Guest User 2/9/18

The Alliance is Grateful to Dr. Gottlieb for Addressing Our Members on February 6 and more

Read More
Advocacy at a Glance Guest User 2/2/18 Advocacy at a Glance Guest User 2/2/18

Opportunities to Become More Involved with the Alliance and more

Read More
Advocacy at a Glance Guest User 1/27/18 Advocacy at a Glance Guest User 1/27/18

Shutdown Ends, but Without a Deal; Next CR Runs Until February 8 and more

Read More
Advocacy at a Glance Guest User 1/19/18 Advocacy at a Glance Guest User 1/19/18

Government Shutdown Seems Likely

Read More
Advocacy at a Glance Guest User 1/13/18 Advocacy at a Glance Guest User 1/13/18

Progress Reported on Budget Deal. But Congress Unlikely to Meet January 19 Deadline and more

Read More
Advocacy at a Glance Guest User 1/5/18 Advocacy at a Glance Guest User 1/5/18

Budget Deal Still Elusive as Congress Faces a January 19 Deadline and more

Read More
Newer Posts
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.